
Imke Satzger
Carl Neuberg Str. 1
Hannover, NI 30625, Germany
Hannover, NI 30625, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study.
Journal: Frontiers in oncology
Published: February 25, 2021
Title Not Found
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: December 29, 2020
Successful treatment of a metastatic melanoma with Talimogen laherparepvec (T-VEC) in a liver transplant patient.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: September 28, 2020
Diagnosis and Differential Diagnosis of Neurological Adverse Events during Immune Checkpoint Inhibitor Therapy.
Journal: Journal of oncology
Published: September 20, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma.
Journal: Nature medicine
Published: June 21, 2020
Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook.
Journal: Journal of clinical medicine
Published: September 16, 2019
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 19, 2019
Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 09, 2019
Acute progressive neuropathy-myositis-myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanoma.
Journal: Melanoma research
Published: March 12, 2019
Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation.
Journal: Journal of skin cancer
Published: November 15, 2018
Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases.
Journal: Cancer immunology, immunotherapy : CII
Published: October 04, 2018
Last Updated: 09/26/2026